Trinity Biotech Plc - ADR
TRIB
Get informed when a big investor buys or sells
+ FollowMarket Cap$146.41M
Close$
$-0.55
107.9% downside
Current Fair Value
107.9% downsideOvervalued by 107.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $146.41 Million |
|---|---|
| Enterprise Value | $279.26 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-60 |
| Beta | 0.97 |
| Outstanding Shares | 620,920 |
Return
| Return on Equity | 51.99% |
|---|---|
| Return on Assets | -35.58% |
| Return on Invested Capital | 38.28% |
Valuation & Multiples
| P/E Ratio | -0.12 |
|---|---|
| PEG | -3.99 |
| Price to Sales | 0.1 |
| Price to Book Ratio | -0.06 |
| Enterprise Value to Revenue | 6.37 |
| Enterprise Value to EBIT | -20.24 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | -1.92 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 3, 2026
EPS Estimate
$-7.80
Average shareholder expectationRevenue Estimate
$10.31 M
Average shareholder expectationNext Earnings Call
Expected Date
December 10, 2026
EPS Estimate
$-8.40
Average shareholder expectationRevenue Estimate
$9.95 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 49,700▲ 74.39% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.35%▼ 0.43% |
|---|---|
| Total Invested | $379,459▼ 35.56% |
| Investors Holding | 20▼ 5.00% |
ESG Score
No data